INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Mar 2, 2017
Document Date
Mar 2, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
Fenimore Christopher R.